INTERVENTIONAL AND STRUCTURAL CARDIOLOGIST BROADENS HOBART’S SURGICAL ABILITIES Tasmanian born, bred and educated cardiologist
With
Dr Heath Adams,
Interventional and Structural Cardiologist
Director of Structural Intervention, Royal Hobart Hospital &
Visiting Medical Officer (VMO) Cardiologist
Hobart Private Hospital &
Adjunct Senior Researcher
Menzies Institute for Medical Research,
University of Tasmania
PEOPLE IN HEATH CARE | AUSTRALIAN HEATH JOURNAL SEGMENT
Filmed in Hobart | March 2025
Dr Heath Adams is a Tasmanian born, bred and educated interventional and structural cardiologist who works at Hobart Private and Royal Hobart Hospital and is a researcher through the Menzies Research Institute.
Dr Adams clinical interest and expertise is in the management of aortic stenosis, valvular heart disease and acute coronary syndromes. Dr Adams performs coronary interventions including stenting, and structural heart interventions including TAVI, mitral edge to edge repair, mitral valve replacement and left atrial appendage closure. In 2020, Heath performed the first TAVI in Tasmania, is the clinical lead for the local program at the Royal Hobart Hospital and is a nationally accredited TAVI practitioner.
Dr Adams achieved First Class Honours in MBBS at UTAS in 2009. He achieved a Fellowship of the Royal College of Physicians in Adult Cardiology in 2016 after training appointments in Victoria. In 2019, he was the structural heart fellow at St Thomas’ Hospital, London, a worldwide centre of excellence in TAVI and structural heart procedures. This fellowship was supported by the prestigious Dr MG Ciezar Memorial Scholarship in cardiovascular medicine from the University of Tasmania.
Dr Adams has published over 50 manuscripts and abstracts in peer-reviewed journals and has been involved in authoring educational book chapters on TAVI. His current research involves streamlined TAVI, assessing frailty outcomes post valve intervention and performing large-scale real-world outcomes with new structural heart interventions. Dr Adams is a clinical supervisor for trainee physicians at the Royal Hobart Hospital, is a member of the CSANZ Interventional Council.
Heath is passionate about clinical innovation, research and patient outcomes. In his free time, Heath enjoys bushwalking, running, cycling and trying to better his golf game whilst being a busy father to 3 children under the age of 6.
Source: supplied and supplemented
-
HIGHLIGHTS Consumers and communities as agents of health care change and improvement
Policymakers, health administrators and clinicians must learn and embrace new ways to harness the transformative role consumers, community members and carers can play. Conversely, consumers and communities need support, capability and capacity to engage as equals in policy, research, program and service design. This is necessary if are to be less technocratic and realise the vision where all members of society can live the best life possible.
-
Diary of a Paramedic in a primary health care clinic
Alecka Miles is a lecturer at Edith Cowan University and works as a paramedic in a multidisciplinary team at Dianella Family Medical Centre in Metropolitan Perth, Western Australia.
Community paramedic roles have a history in Australia, dating back to 2007 in New South Wales and followed by similar initiatives in South Australia and New Zealand. Alecka’s position emerged after she sought to evaluate how paramedics could integrate into general practice, ultimately leading to a job offer post-COVID lockdown in 2020. Her skills, particularly in cannulation, proved valuable as healthcare shifted towards primary care.
-
Breaking silos to transform women’s health through MedTech
In an interview with Australian Health Journal, Jasjit Baveja, Director of Regulatory and Industry Policy at the Medical Technology Association of Australia (MTAA), highlighted the growing importance of medical technology in addressing longstanding inequities in women’s health.
Drawing on the outcomes of the inaugural MTAA Women’s Health MedTech Summit, she explained how the event brought together clinicians, researchers, industry leaders, regulators, investors, government representatives and patient advocates to tackle complex challenges through a collaborative approach.
